Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 14, 2013; 19(46): 8468-8473
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8468
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8468
Early stage colon cancer
Hugh James Freeman, Department of Medicine, University of British Columbia, Vancouver V6T 1W5, Canada
Author contributions: Freeman HJ solely contributed to this paper.
Correspondence to: Hugh James Freeman, MD, CM, FRCPC, FACP, Professor, Department of Medicine, University of British Columbia, 2211 Wesbrook Mall, Vancouver V6T 1W5, Canada. hugfree@shaw.ca
Telephone: +1-604-8227216 Fax: +1-604-8227236
Received: September 29, 2013
Revised: November 6, 2013
Accepted: November 28, 2013
Published online: December 14, 2013
Processing time: 79 Days and 11.4 Hours
Revised: November 6, 2013
Accepted: November 28, 2013
Published online: December 14, 2013
Processing time: 79 Days and 11.4 Hours
Core Tip
Core tip: Evidence has now accumulated that colonoscopy and removal of polyps, especially during screening and surveillance programs, is effective in overall risk reduction for colon cancer. After resection of malignant pedunculated colon polyps or early stage colon cancers, long-term repeated surveillance programs can also lead to detection and removal of asymptomatic high risk advanced adenomas and new early stage metachronous cancers. In future, novel imaging technologies (e.g., confocal endomicroscopy), coupled with increased pathological recognition of high risk markers for lymph node involvement (e.g., “tumor budding”) should lead to improved staging and clinical care.